Publication Date
| In 2025 | 0 |
| Since 2024 | 0 |
| Since 2021 (last 5 years) | 0 |
| Since 2016 (last 10 years) | 0 |
| Since 2006 (last 20 years) | 2 |
Descriptor
| Cognitive Processes | 2 |
| Pain | 2 |
| Patients | 2 |
| Scores | 2 |
| Sleep | 2 |
| Attention Deficit… | 1 |
| Check Lists | 1 |
| Children | 1 |
| Comparative Analysis | 1 |
| Control Groups | 1 |
| Diagnostic Tests | 1 |
| More ▼ | |
Source
| Child Psychiatry and Human… | 2 |
Author
| Agaoglu, Belma | 1 |
| Bell, David S. | 1 |
| De Meirleir, Kenny | 1 |
| Jason, Leonard | 1 |
| Karakaya, Isik | 1 |
| Lapp, Charles W. | 1 |
| Memik, Nursu Cakin | 1 |
| Porter, Nicole | 1 |
| Rowe, Kathy | 1 |
| Shelleby, Elizabeth | 1 |
| Sismanlar, Sahika G. | 1 |
| More ▼ | |
Publication Type
| Journal Articles | 2 |
| Reports - Evaluative | 1 |
| Reports - Research | 1 |
Education Level
Audience
Location
Laws, Policies, & Programs
Assessments and Surveys
What Works Clearinghouse Rating
Peer reviewed
Direct linkYildiz, Ozlem; Sismanlar, Sahika G.; Memik, Nursu Cakin; Karakaya, Isik; Agaoglu, Belma – Child Psychiatry and Human Development, 2011
The aim of this study was to compare the safety, efficacy, tolerability, and the effects of atomoxetine and OROS-MPH on executive functions in children with ADHD. This study was an open-label study that only included two medication groups. Children were randomized to open-label atomoxetine or OROS-MPH for 12 weeks. Primary efficacy measures were…
Descriptors: Pain, Safety, Attention Deficit Hyperactivity Disorder, Patients
Jason, Leonard; Porter, Nicole; Shelleby, Elizabeth; Till, Lindsay; Bell, David S.; Lapp, Charles W.; Rowe, Kathy; De Meirleir, Kenny – Child Psychiatry and Human Development, 2009
The new diagnostic criteria for pediatric ME/CFS are structurally based on the Canadian Clinical Adult case definition, and have more required specific symptoms than the (Fukuda et al. Ann Intern Med 121:953-959, 1994) adult case definition. Physicians specializing in pediatric ME/CFS referred thirty-three pediatric patients with ME/CFS and 21…
Descriptors: Control Groups, Physicians, Evaluation Criteria, Diagnostic Tests
